Details

Autor(en) / Beteiligte

• Clarke, Sarah L. N.
• Mitchell, Ruth E.
• Sharp, Gemma C.
• Ramanan, Athimalaipet V.
• Relton, Caroline L.

Titel

Vitamin D Levels and Risk of Juvenile Idiopathic Arthritis: A Mendelian Randomization Study

Ist Teil von

• Arthritis care & research (2010), 2023-03, Vol.75 (3), p.674-681

Ort / Verlag

Boston, USA: Wiley Periodicals, Inc

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Wiley Blackwell Single Titles

Beschreibungen/Notizen

• Objectives Observational studies report mixed findings regarding the association between vitamin D and juvenile idiopathic arthritis (JIA) incidence or activity; however, such studies are susceptible to considerable bias. Because low vitamin D levels are common within the general population and easily corrected, there is potential public health benefit in identifying a causal association between vitamin D insufficiency and JIA incidence. To limit bias due to confounding and reverse causation, we examined the causal effect of the major circulating form of vitamin D, 25‐hydroxy vitamin D (25‐[OH]D), on JIA incidence using Mendelian randomization (MR). Methods In this 2‐sample MR analysis, we used summary level data from the largest and most recent genome‐wide association study of 25‐(OH)D levels (sample size 443,734), alongside summary data from 2 JIA genetic studies (sample sizes 15,872 and 12,501), all from European populations. To test and account for potential bias due to pleiotropy, we employed multiple MR methods and sensitivity analyses. Results We found no evidence of a causal relationship between genetically predicted 25‐(OH)D levels and JIA incidence (odds ratio 1.00 [95% confidence interval (95% CI) 0.76, 1.33] per SD increase in standardized natural‐log transformed 25‐[OH]D levels). This estimate was consistent across all methods tested. Additionally, there was no evidence that genetically predicted JIA causally influences 25‐(OH)D levels (−0.002 SD change in standardized natural‐log transformed 25‐[OH]D levels per doubling odds in genetically predicted JIA [95% CI −0.006, 0.002]). Conclusion Given the lack of a causal relationship between 25‐(OH)D levels and JIA, population level vitamin D supplementation is unlikely to reduce JIA incidence.